August 2025

ONCOLOGY

IMPACT OF ERASGLUSIB: INSIGHTS FROM DEVALINGAM MAHALINGAM, MD, PHD

Featuring: ​Devalingam Mahalingam, MD, PhD

Episode Summary
In this video, Devalingam Mahalingam, MD, PhD, reviews his ASCO presentation of results from a study on the impact of erasglusib, a treatment started at Northwestern Medicine, on previously untreated metastatic pancreatic ductal adenocarcinoma.
Devalingam Mahalingam, MD, PhD, Professor of Hematology and Oncology at Northwestern Medicine

Refer a Patient

Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients. ​

You May Also Like